GrapheneDx
PrivateLast Round
Series B
Apr 27, 2024
Company Overview
GrapheneDx is a health-diagnostics company that develops graphene-based biosensor technology for point-of-care and at-home diagnostic testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Sensors, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GrapheneDx Comparables
Compare GrapheneDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GRIP Molecular Technologies | 89% | |
| Sapphiros | 85% | |
| Nanopath | 77% | |
GrapheneDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 27, 2024 | ||||
| Strategic | Jul 21, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Monthly visitors grew 1165% MoM, reaching 1.1K.
- Apr 27, 2024
$25M round completed.
GrapheneDx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GrapheneDx's valuation, stock price, and market status.